Yong Song

机构：Nanjing University of Chinese Medicine, Shandong University, Sun Yat-sen University, Fudan University, Nanjing General Hospital of Nanjing Military Command, Southeast University, Hebei Yiling Hospital, Nanjing Drum Tower Hospital, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University, Second Affiliated Hospital of Nanjing Medical University, Central Hospital of Zibo, Intelligent Health (United Kingdom), Jinling Institute of Technology, Southern Medical University, Southeast University, Nanjing Medical University, Michigan State University, Nanjing University · ORCID：0000-0003-4979-4131

发表论文 562 篇 · 总被引 16761 次 · h-index 66

代表论文

• ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages (2024 · Journal of Experimental & Clinical Cancer Research · 被引 47)
• Tislelizumab plus chemotherapy versus chemotherapy alone as first-line treatment for advanced squamous non-small-cell lung cancer: final analysis of the randomized, phase III RATIONALE-307 trial (2024 · ESMO Open · 被引 43)
• Targeted Initiation of Trained Immunity in Tumor-Associated Macrophages with Membrane-Camouflaged Bacillus Calmette-Guérin for Lung Carcinoma Immunotherapy (2024 · ACS Nano · 被引 26)
• Intrinsic STING of CD8 + T cells regulates self-metabolic reprogramming and memory to exert anti-tumor effects (2025 · Cell Communication and Signaling · 被引 15)
• Intrapleural dual blockade of IL-6 and PD-L1 reprograms CAF dynamics and the tumor microenvironment in lung cancer-associated malignant pleural effusion (2025 · Respiratory Research · 被引 14)
• LKB1 dictates sensitivity to immunotherapy through Skp2-mediated ubiquitination of PD-L1 protein in non-small cell lung cancer (2024 · Journal for ImmunoTherapy of Cancer · 被引 14)